Coherus Oncology, Inc. - Common Stock (CHRS)

Historical Holders from Q4 2014 to Q2 2025

Symbol
CHRS on Nasdaq
CUSIP
19249H103
Type / Class
Equity / Common Stock
Shares outstanding
115M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
55.4M
Holdings value
$40.4M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
109
Number of buys
47
Number of sells
-52
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Coherus Oncology, Inc. - Common Stock (CHRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.6% -30% $6.4M -$2.9M 7.62M -31.2% BlackRock, Inc. Mar 31, 2025
SATTERFIELD THOMAS A JR 5.2% $5.05M 6.01M Thomas A. Satterfield, Jr. Apr 14, 2025
Rubric Capital Management LP 4.56% $4.42M 5.26M Rubric Capital Management LP Dec 31, 2024

Institutional Holders of Coherus Oncology, Inc. - Common Stock (CHRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 55.4M $40.4M -$4.93M $0.73 109
2025 Q1 62.1M $50.1M -$6.46M $0.81 114
2024 Q4 65.6M $90.5M -$12.5M $1.38 121
2024 Q3 76.9M $79.9M -$12M $1.04 128
2024 Q2 81.7M $141M -$567K $1.73 132
2024 Q1 82.5M $197M -$7.27M $2.39 133
2023 Q4 320K $1.07M +$720K $3.33 3
2023 Q3 92.9M $348M +$14.5M $3.74 167
2023 Q2 86.7M $370M +$30.6M $4.27 159
2023 Q1 78.4M $536M -$2.03M $6.84 163
2022 Q4 78.6M $622M +$4.1M $7.92 158
2022 Q3 76.9M $739M -$15.2M $9.61 164
2022 Q2 78.1M $566M +$18M $7.24 168
2022 Q1 75.4M $972M -$15M $12.91 168
2021 Q4 75.8M $1.21B +$10.3M $15.96 187
2021 Q3 74.8M $1.2B -$20.6M $16.07 181
2021 Q2 77M $1.07B -$38.2M $13.83 181
2021 Q1 79.4M $1.16B -$125M $14.61 200
2020 Q4 86.1M $1.5B +$7.55M $17.38 188
2020 Q3 87.6M $1.61B -$15.5M $18.34 198
2020 Q2 86.5M $1.54B +$223M $17.86 184
2020 Q1 70.3M $1.14B +$20.8M $16.22 181
2019 Q4 72.3M $1.3B +$58.2M $18.00 182
2019 Q3 68.7M $1.39B +$50.2M $20.26 162
2019 Q2 66.2M $1.46B +$24.7M $22.10 140
2019 Q1 64.6M $881M +$50.9M $13.64 112
2018 Q4 63.3M $573M -$18M $9.05 105
2018 Q3 57M $941M +$38.9M $16.50 104
2018 Q2 61.9M $866M +$96.2M $14.00 111
2018 Q1 55.3M $611M +$32.9M $11.05 102
2017 Q4 49.1M $432M +$14.8M $8.80 90
2017 Q3 46.9M $627M +$87.7M $13.35 90
2017 Q2 39.7M $569M +$24.4M $14.35 102
2017 Q1 37.3M $788M +$211M $21.15 107
2016 Q4 29.6M $832M +$50.9M $28.15 120
2016 Q3 27.8M $743M +$77.9M $26.78 115
2016 Q2 25.3M $428M +$112M $16.89 84
2016 Q1 18M $381M +$29.1M $21.23 72
2015 Q4 16.6M $382M +$9.73M $22.96 76
2015 Q3 14.5M $291M +$15.6M $20.04 74
2015 Q2 14.9M $431M +$228M $28.90 71
2015 Q1 5.71M $174M -$28.1M $30.58 48
2014 Q4 8.29M $132M +$132M $16.32 35